182 related articles for article (PubMed ID: 24876772)
21. Photochemical internalization for pDNA transfection: evaluation of poly(d,l-lactide-co-glycolide) and poly(ethylenimine) nanoparticles.
Gargouri M; Sapin A; Arıca-Yegin B; Merlin JL; Becuwe P; Maincent P
Int J Pharm; 2011 Jan; 403(1-2):276-84. PubMed ID: 21044878
[TBL] [Abstract][Full Text] [Related]
22. PLGA nanoparticle formulations of risperidone: preparation and neuropharmacological evaluation.
Muthu MS; Rawat MK; Mishra A; Singh S
Nanomedicine; 2009 Sep; 5(3):323-33. PubMed ID: 19523427
[TBL] [Abstract][Full Text] [Related]
23. Influence of cationic lipid concentration on properties of lipid-polymer hybrid nanospheres for gene delivery.
Bose RJ; Arai Y; Ahn JC; Park H; Lee SH
Int J Nanomedicine; 2015; 10():5367-82. PubMed ID: 26379434
[TBL] [Abstract][Full Text] [Related]
24. Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma.
Cosco D; Cilurzo F; Maiuolo J; Federico C; Di Martino MT; Cristiano MC; Tassone P; Fresta M; Paolino D
Sci Rep; 2015 Dec; 5():17579. PubMed ID: 26620594
[TBL] [Abstract][Full Text] [Related]
25. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.
Chung YI; Kim JC; Kim YH; Tae G; Lee SY; Kim K; Kwon IC
J Control Release; 2010 May; 143(3):374-82. PubMed ID: 20109508
[TBL] [Abstract][Full Text] [Related]
26. Hybrid-modified poly(D,L-lactide-co-glycolide) nanospheres for a novel cellular drug delivery system.
Tahara K; Furukawa S; Yamamoto H; Kawashima Y
Int J Pharm; 2010 Jun; 392(1-2):311-3. PubMed ID: 20347023
[TBL] [Abstract][Full Text] [Related]
27. Preparation and characterization of cationic PLGA nanospheres as DNA carriers.
Ravi Kumar MN; Bakowsky U; Lehr CM
Biomaterials; 2004 May; 25(10):1771-7. PubMed ID: 14738840
[TBL] [Abstract][Full Text] [Related]
28. Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor.
Ignjatović NL; Penov-Gaši KM; Wu VM; Ajduković JJ; Kojić VV; Vasiljević-Radović D; Kuzmanović M; Uskoković V; Uskoković DP
Colloids Surf B Biointerfaces; 2016 Dec; 148():629-639. PubMed ID: 27694053
[TBL] [Abstract][Full Text] [Related]
29. Development of novel cationic chitosan-and anionic alginate-coated poly(D,L-lactide-co-glycolide) nanoparticles for controlled release and light protection of resveratrol.
Sanna V; Roggio AM; Siliani S; Piccinini M; Marceddu S; Mariani A; Sechi M
Int J Nanomedicine; 2012; 7():5501-16. PubMed ID: 23093904
[TBL] [Abstract][Full Text] [Related]
30. Enhanced cellular uptake and biodistribution of a synthetic cannabinoid loaded in surface-modified poly(lactic-co-glycolic acid) nanoparticles.
Durán-Lobato M; Muñoz-Rubio I; Holgado MA; Alvarez-Fuentes J; Fernández-Arévalo M; Martín-Banderas L
J Biomed Nanotechnol; 2014 Jun; 10(6):1068-79. PubMed ID: 24749401
[TBL] [Abstract][Full Text] [Related]
31. Effect of preparative variables on small interfering RNA loaded Poly(D,L-lactide-co-glycolide)-chitosan submicron particles prepared by emulsification diffusion method.
Katas H; Chen S; Osamuyimen AA; Cevher E; Oya Alpar H
J Microencapsul; 2008 Dec; 25(8):541-8. PubMed ID: 18465303
[TBL] [Abstract][Full Text] [Related]
32. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants.
Blanco D; Alonso MJ
Eur J Pharm Biopharm; 1998 May; 45(3):285-94. PubMed ID: 9653633
[TBL] [Abstract][Full Text] [Related]
33. Poly(D,L-lactide-co-glycolide) nanoparticles encapsulated fluorescent isothiocyanate and paclitaxol: preparation, release kinetics and anticancer effect.
Yang H; Li K; Liu Y; Liu Z; Miyoshi H
J Nanosci Nanotechnol; 2009 Jan; 9(1):282-7. PubMed ID: 19441308
[TBL] [Abstract][Full Text] [Related]
34. Degradable copolymer based on amphiphilic N-octyl-N-quatenary chitosan and low-molecular weight polyethylenimine for gene delivery.
Liu C; Zhu Q; Wu W; Xu X; Wang X; Gao S; Liu K
Int J Nanomedicine; 2012; 7():5339-50. PubMed ID: 23071395
[TBL] [Abstract][Full Text] [Related]
35. Characterization of rabies pDNA nanoparticulate vaccine in poloxamer 407 gel.
Bansal A; Wu X; Olson V; D'Souza MJ
Int J Pharm; 2018 Jul; 545(1-2):318-328. PubMed ID: 29746999
[TBL] [Abstract][Full Text] [Related]
36. Calcium phosphate embedded PLGA nanoparticles: a promising gene delivery vector with high gene loading and transfection efficiency.
Tang J; Chen JY; Liu J; Luo M; Wang YJ; Wei XW; Gao X; Wang BL; Liu YB; Yi T; Tong AP; Song XR; Xie YM; Zhao Y; Xiang M; Huang Y; Zheng Y
Int J Pharm; 2012 Jul; 431(1-2):210-21. PubMed ID: 22561795
[TBL] [Abstract][Full Text] [Related]
37. Mucoadhesive DL-lactide/glycolide copolymer nanospheres coated with chitosan to improve oral delivery of elcatonin.
Kawashima Y; Yamamoto H; Takeuchi H; Kuno Y
Pharm Dev Technol; 2000; 5(1):77-85. PubMed ID: 10669921
[TBL] [Abstract][Full Text] [Related]
38. Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid.
Keum CG; Noh YW; Baek JS; Lim JH; Hwang CJ; Na YG; Shin SC; Cho CW
Int J Nanomedicine; 2011; 6():2225-34. PubMed ID: 22114486
[TBL] [Abstract][Full Text] [Related]
39. Development and in vitro evaluation of surface modified poly(lactide-co-glycolide) nanoparticles with chitosan-4-thiobutylamidine.
Grabovac V; Bernkop-Schnürch A
Drug Dev Ind Pharm; 2007 Jul; 33(7):767-74. PubMed ID: 17654025
[TBL] [Abstract][Full Text] [Related]
40. Establishing chitosan coated PLGA nanosphere platform loaded with wide variety of nucleic acid by complexation with cationic compound for gene delivery.
Tahara K; Sakai T; Yamamoto H; Takeuchi H; Kawashima Y
Int J Pharm; 2008 Apr; 354(1-2):210-6. PubMed ID: 18178349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
